1st 24/7, Noninvasive Glucose Monitor
World First Glucose Monitor That's Wearable, Non-Invasive & Continuous
SugarBEAT Monitors Glucose with No Needles
This is top innovation in the medical wearable category from the UK. Nemaura Medical has invented SugarBEAT, the world's first non-invasive, continuous glucose monitor. It's wearable, affordable, small and flexible. And, it just received the CE Mark Approval which means it can begin selling in the European Union. For anyone with diabetes, this may be a godsend.
Wearable Glucose Monitor with Continuous Coverage
The SugarBEAT attaches to the skin by a disposable patch. The patch monitors the wearer's glucose levels and relays it to a paired device. No needle pricks are involved and the system provides a more efficient early warning system.
$179 Billion Market Opportunity
This new innovation is targeted at a huge global market, estimated at $179 billion. The market includes diabetics and pre-diabetics who are insulin & non-insulin dependent and the wearable health technology market. Nemaura Medical will launch SugarBEAT in the UK and Germany this summer.
Simultaneously, it will seek FDA approval to sell in the US. For a free Kindle borrow of my book "List of Best New Innovations", go to amazon.com/author/ekane ASIN: B07NTWC3FW
 |
| Source: Nemaura Medical's SugarBEAT |
SugarBEAT Monitors Glucose with No Needles
This is top innovation in the medical wearable category from the UK. Nemaura Medical has invented SugarBEAT, the world's first non-invasive, continuous glucose monitor. It's wearable, affordable, small and flexible. And, it just received the CE Mark Approval which means it can begin selling in the European Union. For anyone with diabetes, this may be a godsend.
Wearable Glucose Monitor with Continuous Coverage
The SugarBEAT attaches to the skin by a disposable patch. The patch monitors the wearer's glucose levels and relays it to a paired device. No needle pricks are involved and the system provides a more efficient early warning system.
$179 Billion Market Opportunity
This new innovation is targeted at a huge global market, estimated at $179 billion. The market includes diabetics and pre-diabetics who are insulin & non-insulin dependent and the wearable health technology market. Nemaura Medical will launch SugarBEAT in the UK and Germany this summer.
Simultaneously, it will seek FDA approval to sell in the US. For a free Kindle borrow of my book "List of Best New Innovations", go to amazon.com/author/ekane ASIN: B07NTWC3FW
Comments
Post a Comment